Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: P.T.Hadjigeorgiou Co Ltd, P.O.Box 53158-3301, Limassol, Cyprus, Tel: 25372425, Fax: 25376400, e-mail: info.pth@cytanet.com.cy
Diclac.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
Active substance: diclofenac sodium.
Phenyl acetic acid derivative
Non-steroidal antiphlogistic/analgesic
1 ampoule with 3 ml solution for injection contains: diclofenac sodium 75 mg.
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| List of Excipients |
|---|
|
Acetylcysteine |
5, 10 or 20 ampoules with 3 ml injectable solution.
P.T.Hadjigeorgiou Co Ltd, P.O.Box 53158-3301, Limassol, Cyprus, Tel: 25372425, Fax: 25376400, e-mail: info.pth@cytanet.com.cy
018784
MAY 12, 2000
| Drug | Countries | |
|---|---|---|
| DICLAC | Brazil, Cyprus, Germany, Estonia, Croatia, Ireland, Lithuania, Malta, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
